Allergies come in all shapes and sizes ...
Just like allergy sufferers. And they are on the rise. For many people allergies can range from sniffling and sneezing to skin rashes to gastrointestinal issues. A certain percentage, however, have more than these uncomfortable symptoms to deal with. Anaphylaxis, a serious life-threatening reaction, causes approximately 1,500 deaths a year in the United States alone. Clearly, allergies are nothing to sneeze at!
Articles for Advocacy
The FASTER Act: What It Does and Why YOU Need to Help Pass It
Probably everyone has heard the expression “the squeaky wheel gets the grease.” What they may not have heard is the reason why; “because it needs it!” Congress is currently considering the FASTER Act which will, amongst other things, expand the FALCPA “Top 8” allergens to include sesame as the ninth. Here you will find a summary of what is the FASTER ACT complied by Food Allergy Research and Education (FARE) as well as information on their Courage at Congress Campaign to encourage your legislators to co-sponsor and show their support for the FASTER Act.
Having a potential life threating allergy impacts a person’s life in many ways. One way is the medicine you use to treat your allergy and how it is administered. Now what if the Food and Drug Administration (FDA) approved a treatment that could make it easier to use, as in the case of dissolving epinephrine, or more convenient as in the case of at-home asthma injections, it could be game changer for allergy suffers as well as their friends and family. Read here about the efforts of two pharmaceuticals companies that are attempting to create these game changers.
Allergy News: Dissolving Epinephrine, At-Home Asthma Injections
By: Jenifer Goodwin
August 26, 2020
An Oral Epinephrine ‘Film’ to Stop Allergic Reactions?
The hesitancy of some people to use an epinephrine auto-injector for anaphylaxis has led to a longstanding interest in developing an alternative that doesn’t involve a needle.
While efforts to develop an oral, sublingual epinephrine pill have yet to succeed, Aquestive Therapeutics, based in New Jersey, just launched a Phase 1 clinical trial of an epinephrine “film” that dissolves under the tongue. The trial, which will enroll up to 28 people, will compare the effectiveness of the film with epinephrine given by injection.
Teva Pharmaceuticals, one of the world’s largest makers of generic drugs, may soon be indicted by the U.S. Department of Justice. This most recent investigation by the DOJ focused on Teva and other drug companies conspiring to fix prices on several widely used generic medications.
Teva Posed to Face Charges in Drug Price-Fixing Probe
By David McLaughlin
August 25, 2020
DOJ preparing criminal antitrust complaint against drug-maker
U.S. prosecutors are preparing to charge Teva Pharmaceutical Industries Ltd. with conspiring with competitors to raise prices for generic drugs, according to a person familiar with the matter.
The Justice Department is planning to charge Teva as soon as Tuesday after the company rebuffed a settlement that would have required paying a criminal penalty and admitting wrongdoing, said the person, who declined to be named because the matter is confidential.
Upcoming Events